Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 18 (N.D.W.Va. Mar. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 18 (N.D.W.Va. Mar. 29, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 15 (N.D.W.Va. Mar. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 15 (N.D.W.Va. Mar. 29, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 8 (N.D.W.Va. Mar. 28, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 8 (N.D.W.Va. Mar. 28, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 7 (N.D.W.Va. Mar. 25, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 7 (N.D.W.Va. Mar. 25, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 23 (N.D.W.Va. May. 9, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 23 (N.D.W.Va. May. 9, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 21 (N.D.W.Va. Apr. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 21 (N.D.W.Va. Apr. 29, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 19 (N.D.W.Va. Apr. 8, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 19 (N.D.W.Va. Apr. 8, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 11 (N.D.W.Va. Mar. 28, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 11 (N.D.W.Va. Mar. 28, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 12 (N.D.W.Va. Mar. 28, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 12 (N.D.W.Va. Mar. 28, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 9 (N.D.W.Va. Mar. 28, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 9 (N.D.W.Va. Mar. 28, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 10 (N.D.W.Va. Mar. 28, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 10 (N.D.W.Va. Mar. 28, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2 (N.D.W.Va. Mar. 18, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2 (N.D.W.Va. Mar. 18, 2022)
+ More Snippets
Document
IPR2022-00657, No. 16 Notice refund approved - Notice refund approved (P.T.A.B. Sep. 13, 2022)
Cite Document
IPR2022-00657, No. 16 Notice refund approved - Notice refund approved (P.T.A.B. Sep. 13, 2022)
+ More Snippets
Document
IPR2022-00657, No. 14 Termination Decision Pre DI settlement - Termination Decision Pre DI settlement (P.T.A.B. Sep. 8, 2022)
Cite Document
IPR2022-00657, No. 14 Termination Decision Pre DI settlement - Termination Decision Pre DI settlement (P.T.A.B. Sep. 8, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 34 (N.D.W.Va. Aug. 5, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 34 (N.D.W.Va. Aug. 5, 2022)
+ More Snippets